If you want to know Bionaturis Group latest news, here you are our February Newsletter

Imagen Bionaturis Newsletter

IN THIS ISSUE

    • Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS)
    • Bionaturis Group is attending the European Animal Health Investment Forum in London this week
  • Bionaturis, honoured with the prize by Actualidad Economica Magazine within the ‘Revelation’ category

Let’s get to know…

Andoni Cruz, 44 years old, born in Bilbao. Degree in Sciences and Master in Applied Biology.

 

Andoni Cruz

  • -When you were a child, what did you want to be as an adult?
  • Since I was a very young I liked swimming and scuba-diving so I always wanted to be a Marine Biologist.
  • -What do you like the most about your job?
  • Being able to create something new from scratch, the generation of innovative projects that may contribute to improve our society.
  • -What are your future challenges?
  • The main goal is to turn Biobide into the global company of reference for essays with zebrafish. To achieve that, we must consolidate our expansion strategy in the USA and China and complete our landing at LATAM and Japan.
  • -Your favourite dish
  • A large steak.
  • -A place
  • ‘The Lighthouse’, an ideal place to immerse yourself in the beauty of the Cantabrian Sea.
  • -A film
  • I love cinema. If I have to choose one film, I will probably select ‘The Godfather’.
  • -A historical figure
  • Jacques Cousteau.
  • -A book
  • ‘1984’, by George Orwell.
  • -A song
  • One of the songs that has influenced on me is ‘With or Without You’, by U2.
  • -What do you usually do in your free time?
  • Relaxing with my friends and relatives, skiing or scuba-diving.
  • -You can’t live without…
  • My family and the sea nearby.
  • -How do you imagine the world in 20 years?
  • We will be probably conected 24 hours per day through devices integrated in our bodies in a non-invasive way, the revolution of the stem cells will offer a new view and a great part of current diseases could be treated with these therapies. The level of poverty in the world will be reduced and the relevance of renewable and nuclear energy (fision/fusion) will be decisive.
Andoni is the co-founder of Biobide and has been working as the General Manager since January, 2013.

Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS)

BBD BioPhenix-Biobide (now part of Bionaturis Group), has recently signed a contract agreement with one of the U.S. National Institutes of Health, the National Institute of Environmental Health Sciences (NIH-NIEHS), for analyzing the impact of exposure to different chemicals with unknown toxicological potential in zebrafish embryos. Biobide provides zebrafish-based services in the preclinical area, mainly toxicology, through early detection of adverse effects in a Good Laboratory Practice (GLP) setting […] Read more

Bionaturis Group is attending the European Animal Health Investment Forum in London this week

Bionaturis Group (ticker BNT), a partner of reference for animal health products development, has announced that Mr Victor Infante, CEO of the group, will attend the European Animal Health Investment Forum, held in London this week. This event, considered one of the most important ones in Europe in Animal Health, will be celebrated next February, 10-11th. The event features networking opportunities with high-profile attendess including investors, c-level excecutives from both multinational and emerging companies, academia, etc […] Read more

Bionaturis, honoured with
the prize by Actualidad Economica Magazine within the ‘Revelation’ category

The readers of Actualidad Economica Magazine had chosen Bionaturis as Revelation Company, for its Business Success Awards in the province of Cadiz. As it has been announced today in its February issue, Bionaturis was born as a Spin-Off at Cadiz University ten years ago and today it is a reference company in the development of state-of-the-art biological medicines. According to its vision to offer a more balanced access to first-in-class drugs in the world, Bionaturis is nowadays developing its international expansion […]
Read more

INVESTOR INFO

General info: Articles of Association (only in Spanish)
General info: Regulations of the General Meeting of Shareholders (only in Spanish)


Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis
Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto? No quiero seguir recibiendo este newsletter Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|*

*|REWARDS|*